NR3C1 and chronic obstructive pulmonary disease: In patients with COPD, data exist that other mechanisms of glucocorticoid resistance are present, particularly as it pertains to changes in histone deacetylase activity, which leads to a decreased availability of glucocorticoid binding sites in the nucleus [34] and phosphorylation of the GR by serine proteases [35].